One hundred and eighty HIV positive people who do not have access to subsidised antiretroviral drugs on the PBS[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. will soon receive free treatment over 48 months, when a long anticipated study commences recruitment in early October.
The Medicare Ineligibles Access Study is the result of collaboration between NAPWHA, the Kirby Institute and the seven pharmaceutical companies who provide antiretroviralsA medication or other substance which is active against retroviruses such as HIV. in this country.
Patients will be recruitedThe act of signing up participants into a study. Generally this process involves evaluating a participant with respect to the eligibility criteria of the study and going through the informed consent process. according to clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. need and financial hardship from over twenty clinics around Australia.
‘While limited in scope, the study will at least address the problem of no treatment access for a number of people,’ said Jo Watson, NAPWHA’s Executive Director.
‘The data will also help us advocate for others in the future as we continue our negotiations with government,’ she said.
Anyone who believes they may qualify is encouraged to talk to their doctor as soon as possible.